Literature DB >> 28546928

Modified deep sclerectomy combined with Ex-PRESS filtration device versus trabeculectomy for primary open angle glaucoma.

Vassilios Kozobolis1,2,3, Georgios D Panos2, Aristeidis Konstantinidis1, Miguel Teus4, Georgios Labiris1,2.   

Abstract

AIM: To compare the efficacy of modified deep sclerectomy combined with Ex-PRESS shunt versus trabeculectomy in primary open angle glaucoma.
METHODS: This is a prospective cohort comparative single-center study. Forty-nine eyes of 49 patients were enrolled in the study. Patients were randomly divided into two groups. Group A (22 patients) underwent classic trabeculectomy and group B (27 patients) underwent modified deep sclerectomy combined with insertion of Ex-PRESS model P50 drainage device.
RESULTS: Mean age was 69±7y in group A and 64±8y in group B (P=0.03). The mean reduction was 11.1±5.7 mm Hg in group A compared to 15.8±5.7 mm Hg in group B at 6mo (P=0.006), and 9.8±4.9 mm Hg and 15.4±4.7 mm Hg respectively at 1y (P=0.0001). Regarding the postoperative glaucoma medication, significant difference was observed between the two groups (in favour of group B) only at 6mo (P=0.017). At the end of the follow-up period complete success rate in group A was 68.2% compared to 92.6% in group B (χ2 test, P=0.07) and qualified success rate was 100% in both groups.
CONCLUSION: Modified deep sclerectomy combined with Ex-PRESS shunt may provide comparable IOP reduction with fewer complications in management of primary open angle glaucoma.

Entities:  

Keywords:  Ex-PRESS drainage device; glaucoma; modified deep sclerectomy; trabeculectomy

Year:  2017        PMID: 28546928      PMCID: PMC5437459          DOI: 10.18240/ijo.2017.05.11

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  29 in total

1.  Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).

Authors:  Peter A Netland; Steven R Sarkisian; Marlene R Moster; Iqbal Ike K Ahmed; Garry Condon; Sarwat Salim; Mark B Sherwood; Carla J Siegfried
Journal:  Am J Ophthalmol       Date:  2013-11-07       Impact factor: 5.258

2.  Combined Ex-PRESS LR-50/IOL implantation in modified deep sclerectomy plus phacoemulsification for glaucoma associated with cataract.

Authors:  Fanny Gindroz; Sylvain Roy; André Mermoud; Corinne C Schnyder
Journal:  Eur J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 2.597

3.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

4.  Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective, randomised study.

Authors:  E Dahan; G J Ben Simon; A Lafuma
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

Review 5.  Ciliochoroidal detachment.

Authors:  R F Brubaker; J E Pederson
Journal:  Surv Ophthalmol       Date:  1983 Mar-Apr       Impact factor: 6.048

6.  Trabeculectomy vs. nonpenetrating trabeculectomy: a retrospective study of two procedures in phakic patients with glaucoma.

Authors:  T J Zimmerman; K S Kooner; V J Ford; K W Olander; R M Mandlekorn; E F Rawlings; B J Leader; A J Koskan
Journal:  Ophthalmic Surg       Date:  1984-09

Review 7.  Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.

Authors:  Eliana Rulli; Elena Biagioli; Ivano Riva; Giovanni Gambirasio; Irene De Simone; Irene Floriani; Luciano Quaranta
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

8.  Collaborative Initial Glaucoma Treatment Study: a summary of results to date.

Authors:  Leonard Feiner; Jody R Piltz-Seymour
Journal:  Curr Opin Ophthalmol       Date:  2003-04       Impact factor: 3.761

9.  Delayed nonexpulsive suprachoroidal hemorrhage.

Authors:  M G Gressel; R K Parrish; D K Heuer
Journal:  Arch Ophthalmol       Date:  1984-12

10.  Modified deep sclerectomy (D-lectomy MMC) for primary open-angle glaucoma: preliminary results.

Authors:  Etsuo Chihara; Kazushiro Okazaki; Hirokazu Takahashi; Takuhei Shoji; Hatsuto Adachi; Ken Hayashi
Journal:  J Glaucoma       Date:  2009-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.